drug

Bapotulimab

Phase 1updated 3mo ago

by Bayer AG

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Bapotulimab

phase1Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.completedn=60

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed just now

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

Bapotulimab

Phase 1updated 3mo ago

by Bayer AG

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Bapotulimab

phase1Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.completedn=60

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed just now

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Bapotulimab

all catalysts(0)

Trials studying Bapotulimab

News(0)

Report a data issue

comments(0)

Bapotulimab

all catalysts(0)

Trials studying Bapotulimab

News(0)

Report a data issue

comments(0)